NN Inc (NNBR)

NASDAQ
7.14
+0.06(+0.85%)
After Hours
7.22
+0.08(+1.12%)
- Real-time Data
  • Volume:
    122,044
  • Bid/Ask:
    6.76/7.46
  • Day's Range:
    7.00 - 7.22

NNBR Overview

Prev. Close
7.08
Day's Range
7 - 7.22
Revenue
627.29M
Open
7.07
52 wk Range
1.79 - 8.58
EPS
-3.6
Volume
122,044
Market Cap
305.53M
Dividend (Yield)
N/A (N/A)
Average Vol. (3m)
220,427
P/E Ratio
N/A
Beta
3.39
1-Year Change
335.37%
Shares Outstanding
42,791,476
Next Earnings Date
May 13, 2021
What is your sentiment on NN Inc?
or
Market is currently closed. Voting is open during market hours.

NN Inc News

NN Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuyStrong BuyBuySell
Technical IndicatorsStrong BuyStrong BuyStrong BuyBuyBuy
SummaryStrong BuyStrong BuyStrong BuyBuyNeutral

NN Inc Company Profile

NN Inc Company Profile

NN, Inc. is a diversified industrial company and a global manufacturer of high precision components and assemblies to a range of markets on a global basis. The Company's operating segments include: the Precision Engineered Products Group and the Autocam Precision Components Group. Precision Engineered Products Group combines materials science capability with engineering and production solutions to design and manufacture a range of high-precision metal and plastic components, assemblies and finished devices for the medical, electrical, automotive and aerospace end markets. Autocam Precision Components Group manufactures highly engineered, difficult-to-manufacture precision metal components and subassemblies for the automotive, heating, ventilating and air conditioning (HVAC), fluid power and diesel engine end markets.

Read More
  • Warren Veltmen navigated Autocam through the 2009 crisis just as rock Baty did with NNBR.. NN will exceed to leverage covenants in August for FCF will be positive for Q2 with, > $70 in liquidy... the business will survive and then assets need to be sold starting with mobile for $200m a loss to book but great for multiples. The paragon medical centric business with < 4x leverage is worth $18 share alone. I'll remain long but need to see announcements prior to Q2 results call. end of July announce is my pick for now
    1
    • 91% Must be hedge fund. Maybe legion partners added to position
      0
      • better trend today up 70÷
        0
        • why why.... going down everyday...
          0
          • Expect an announcement by April. Split medical into a separate company could be best option. No time to sell mobile today
            1
            • So here's the math NN sells Mobile for $200m, EBITDA multiple goes to 8X immediately and stock goes to $30 or NN is sold for debt plus a little and stock goes to $24 . Either option is 3X growth in 12 months
              0
              • Hope Tom earns his ****salary and 90÷ bonus
                0
                • Next CEO, Tom, made 1st step. Tom and Warren to swap roles by mid 2020?
                  0
                  • down 5%
                    0
                    • Warren spoke
                      0
                      • maybe Warren should say a few words?
                        0
                        • good job Bob...
                          0
                          • Time for Bob Brunner to go. Chairman is accountable too!
                            0
                            • Forward PE is now less than 5
                              0
                              • new CFO announcement should be today after the bell
                                0
                                • Q2 is pivotal
                                  0
                                  • A good Q1 and Q2 forecast tonight ?
                                    0
                                    • Mr Holder has lost the confidence of those who own the company Good strategy but too much BS. He could not even remember his own 3.5 debt to EBITDA goal from the last investor conference. Now saying 4.5 which is a huge miss Time for Rich to go. May board meeting decision? legion may drive this. Accountability!
                                      0
                                      • February 14th or 15th seems to be best date for PGS announcement and 2019 guidance.
                                        0
                                        • Good move on the fixed interest rate and 6 basis point benefit. That's worth $420k in annual earnings. Next step, S.W. needs to be replaced on the board
                                          0
                                          • Here's another way to look at the math in a very non Buffet way. NN before Rich had a market cap of ~$200m. Autocam was bought for $330m, PEP for $615M, Paragon for $375M and Bridgemedica and a few other investments for ~$50m, minus the $375m PBC was sold for. So assuming any reasonable degree on competence in due diligence and assuming zero synergies, this says the stock should be $30 once the new run rate is demonstrated in 2019.
                                            0
                                            • Rich and Paul should move forward on the PGS announcement and include 2019 guidance with a clear roadmap on the growth by product segment
                                              0
                                              • 2019 EBITDA will be > $174M with a Medical and Industrial centric end market focus. A 2X EBITDA multiple will not last long.....
                                                0
                                                • Do the math on the strategic plan presented in September If NN hits 80÷ of there stated five year goals the stock will be well above $60 The strategy makes perfect sense They just need to execute
                                                  0
                                                  Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                                  Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.